Results 1 to 10 of about 1,252,486 (261)

Pulmonary aspergillosis: diagnosis and treatment

European Respiratory Review, 2022
Aspergillus species are the most frequent cause of fungal infections of the lungs with a broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) and chronic pulmonary aspergillosis (CPA).
Frederic Lamoth, Thierry Calandra
doaj   +2 more sources

Invasive Pulmonary Aspergillosis

Journal of Fungi, 2023
Invasive pulmonary aspergillosis is growing in incidence, as patients at risk are growing in diversity. Outside the classical context of neutropenia, new risk factors are emerging or newly identified, such as new anticancer drugs, viral pneumonias and ...
Marie-Pierre Ledoux, R. Herbrecht
semanticscholar   +4 more sources

A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue

American Journal of Respiratory and Critical Care Medicine, 2023
Rationale Invasive pulmonary aspergillosis has emerged as a frequent coinfection in severe coronavirus disease (COVID-19), similarly to influenza, yet the clinical invasiveness is more debated.
L. Vanderbeke, C. Jacobs, S. Feys, Agustin Reséndiz-Sharpe, Y. Debaveye, G. Hermans, S. Humblet-Baron, K. Lagrou, P. Meersseman, M. Peetermans, L. Seldeslachts, A. Vanstapel, G. Vande Velde, E. Van Wijngaerden, A. Wilmer, E. Verbeken, G. De Hertogh, J. Wauters   +17 more
semanticscholar   +3 more sources

A Case Report of Immune Checkpoint Inhibitor-Associated Pneumonia Complicated by Invasive Pulmonary Aspergillosis in a Patient With Chronic Obstructive Pulmonary Disease. [PDF]

Clin Case Rep
ABSTRACT This case reports a patient with chronic obstructive pulmonary disease who developed immune checkpoint inhibitor‐associated pneumonia following immunotherapy, complicated by invasive pulmonary aspergillosis. Such cases are rare and pose diagnostic challenges in clinical practice. The successful diagnosis and treatment of this patient provide a
Lin S.
europepmc   +2 more sources

Lung and gut microbiomes in pulmonary aspergillosis: Exploring adjunctive therapies to combat the disease

Frontiers in Immunology, 2022
Species within the Aspergillus spp. cause a wide range of infections in humans, including invasive pulmonary aspergillosis, chronic pulmonary aspergillosis, and allergic bronchopulmonary aspergillosis, and are associated with high mortality rates.
Liuyang Cai, Liuyang Cai, Peigen Gao, Peigen Gao, Zeyu Wang, Zeyu Wang, Chenyang Dai, Chenyang Dai, Ye Ning, Ye Ning, Macit Ilkit, Xiaochun Xue, Jinzhou Xiao, Chang Chen, Chang Chen   +14 more
doaj   +2 more sources

Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [PDF]

Current Medical Mycology, 2022
Background and Purpose: Influenza A and SARS-CoV-2 are risk factors for invasive pulmonary aspergillosis. Both influenza-associated pulmonary aspergillosis and COVID-19-associated pulmonary aspergillosis result in high mortality and poor clinical ...
Ahsan Syed, Kausar Jabeen, Joveria Farooqi, Hammad Niamatullah, Aisha Fareed Siddiqui, Safia Awan, Alishah Akbar, Irfan Muhammad   +7 more
doaj   +1 more source

Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: a retrospective study

Frontiers in Cellular and Infection Microbiology, 2022
This study aimed to obtain further in-depth information on the value of metagenomic next-generation sequencing (mNGS) for diagnosing pulmonary aspergillosis in non-neutropenic patients.
Shujun Bao, Huihui Song, Yang Chen, Caiming Zhong, Hao Tang   +4 more
doaj   +1 more source

Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis

Journal of Clinical Microbiology, 2023
Timely diagnosis remains an unmet need in non-neutropenic patients at risk for aspergillosis, including those with COVID-19-associated pulmonary aspergillosis (CAPA), which in its early stages is characterized by tissue-invasive growth of the lungs with ...
M. Hoenigl, Egger, J. Price, R. Krause, J. Prattes, Lewis White, Matthias Egger   +6 more
semanticscholar   +1 more source

Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices

Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 2023
The prevalence of invasive pulmonary aspergillosis (IPA) is growing in critically ill patients in the intensive care unit (ICU). It is increasingly recognized in immunocompetent hosts and immunocompromised ones.
S. Gaffney, Dearbhla M Kelly, P. M. Rameli, Eoin M Kelleher, I. Martín-Loeches   +4 more
semanticscholar   +1 more source

Chronic pulmonary aspergillosis - case series and review of Indian literature

Indian Journal of Respiratory Care, 2021
Aspergillus species, especially Aspergillus fumigatus, can cause varied pulmonary manifestations depending on the host immune status and duration of infection. Chronic pulmonary aspergillosis (CPA) is an under-reported entity, and its diagnosis remains a
Vikas Marwah, Robin Choudhary, Deepu K Peter, Gaurav Bhati, Kunal Kumar, R Akhil, Shafin Babu   +6 more
doaj   +1 more source